Neurophth Therapeutics Inc

Neurophth Therapeutics Inc. develops gene therapies for ophthalmic diseases in biotechnology. The company conducts clinical trials for inherited retinal conditions, manufactures gene therapy products using AAV vector technology, and researches treatments for ocular and genetic diseases. It serves patients with inherited eye diseases in the US, China, and Australia.